Generation of allogeneic CAR-T circumvents functional deficits in patientderived autologous product for glioblastoma

被引：0
|
作者：
Shaikh, Muhammad Vaseem
Salim, Sabra K.
Wei, Jeffrey
Maich, William T.
Anand, Alisha A.
Tang, Oliver Young
Subapanditha, Minomi K.
Suk, Yujin
Singh, Manoj
Alizada, Zahra
Brakel, Benjamin
Dimitrov, Vassil
Tabunshchyk, Zoya
Brown, Kevin
Vora, Parvez
Binder, Zev
Venugopal, Chitra
Moffat, Jason
Singh, Sheila K.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5241
引用
收藏
页数：3
相关论文
共 50 条
  • [1] ENHANCING GLIOBLASTOMA TREATMENT: ALLOGENEIC CAR-T CELLS OVERCOMES FUNCTIONAL DEFICITS OF PATIENT-DERIVED AUTOLOGOUS PRODUCTS
    Shaikh, Muhammad Vaseem
    Salim, Sabra K.
    Maich, William T.
    Ananad, Alisha
    Wei, Jeffrey
    Subapanditha, Minomi K.
    Suk, Yujin
    Singh, Manoj
    Tabunshchyk, Zoya
    Chen, Katie
    Vora, Parvez
    Venugopal, Chitra
    Moffat, Jason
    Singh, Sheila K.
    NEURO-ONCOLOGY, 2024, 26
  • [2] Manufacturing of a Subsequent Autologous CAR-T Product after Prior CAR-T Is Safe and Feasible
    Su, Yi-Jiun
    Kramer, Anne Marijn
    Hamilton, Mark P.
    Agarwal, Neha
    Feldman, Steven
    Sahaf, Bita
    Kuo, Adam
    Mackall, Crystal L.
    Muffly, Lori S.
    Miklos, David B.
    Frank, Matthew J.
    BLOOD, 2023, 142
  • [3] Combining locoregional CAR-T cells, autologous plus allogeneic tumor lysate vaccination and levamisole in treatment of glioblastoma
    Altinoz, Meric A.
    Ozpinar, Alp
    Hacker, Emily
    Ozpinar, Aysel
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (06) : 797 - 808
  • [4] Optimizing CAR-T Therapy for Glioblastoma
    Oliver Y. Tang
    Zev A. Binder
    Donald M. O’Rourke
    Stephen J. Bagley
    Molecular Diagnosis & Therapy, 2023, 27 : 643 - 660
  • [5] Optimizing CAR-T Therapy for Glioblastoma
    Tang, Oliver Y.
    Binder, Zev A.
    O'Rourke, Donald M.
    Bagley, Stephen J.
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (06) : 643 - 660
  • [6] ALLOGENEIC CAR-T MADE SIMPLE
    Guerrero, A. Gutierrez
    Abrial, P.
    Da Rocha, M. Neto
    Menkova, I.
    CYTOTHERAPY, 2023, 25 (06) : S227 - S228
  • [7] Multiplex Prime Editing and PASSIGE TM for Non-Viral Generation of an Allogeneic CAR-T Cell Product
    Pomeroy, Emily J.
    Anzalone, Andrew V.
    Podracky, Christopher J.
    Bloch, Noah B.
    Chang, Reyna
    Dwivedi, Arika A.
    Laoharawee, Kanut
    Wilhelm, Alan J.
    Waterman, David P.
    Tedeschi, Justin G.
    Arvindam, Upasana Sunil
    Macari, Elizabeth R.
    Gori, Jennifer L.
    Duffield, Jeremy S.
    BLOOD, 2023, 142
  • [8] Development of an allogeneic product by CAR-T cells TCR knock-down
    Raitano, Susanna
    Bornschein, Simon
    Bolsee, Jennifer
    Marijsse, Jerome
    Marchand, Celine
    Huberty, Fanny
    Violle, Benjamin
    N'Guyen, Thuy
    Jacques-Hespel, Celine
    Ramelot, Nancy
    Houssa, Julien
    Agaugue, Sophie
    Gilham, David Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T Cells
    Juillerat, Alexandre
    Tkach, Diane
    Yang, Ming
    Boyne, Alex
    Valton, Julien
    Poirot, Laurent
    Duchateau, Philippe
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [10] Autologous Lymphapheresis for the Production of CAR-T Cells
    Paciello Coronel, Maria Liz
    Redondo Velao, Sara
    Teresa Cedena, Maria
    Leivas Aldea, Alejandra
    Valeri, Antonio
    Garcia, Almudena
    Andrades Velazquez, Borja
    Sanchez Lozano, Desire
    Guemes Arce, Encarnacion
    Martinez Lopez, Joaquin
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 698 - 698
12345